Multivariate analysis of disease-free survival
| Variables . | Relative risk of treatment failure (95% confidence interval) . | P . |
|---|---|---|
| HLA-identical sibling transplant versus autologous transplant | ||
| First 6 mo after transplantation | 1.49 (0.92-2.40) | .10 |
| Beyond 6 mo after transplantation | 0.58 (0.27-1.22) | .15 |
| Other significant variables | ||
| Disease status at transplantation4-150 | ||
| CR1 | 1.00 | |
| CR2 or more | 1.82 (1.03-3.22) | .04 |
| Relapse 1 or more | 3.17 (1.69-5.32) | < .0001 |
| Primary induction failure | 2.65 (1.55-4.53) | .0004 |
| Variables . | Relative risk of treatment failure (95% confidence interval) . | P . |
|---|---|---|
| HLA-identical sibling transplant versus autologous transplant | ||
| First 6 mo after transplantation | 1.49 (0.92-2.40) | .10 |
| Beyond 6 mo after transplantation | 0.58 (0.27-1.22) | .15 |
| Other significant variables | ||
| Disease status at transplantation4-150 | ||
| CR1 | 1.00 | |
| CR2 or more | 1.82 (1.03-3.22) | .04 |
| Relapse 1 or more | 3.17 (1.69-5.32) | < .0001 |
| Primary induction failure | 2.65 (1.55-4.53) | .0004 |
CR indicates complete remission; and RR, relative risk.
≥ Relapse 1 versus ≥ CR2, RR, 1.74 (95% CI, 1.00-3.03),P = .05; primary induction failure versus ≥ CR2, RR, 1.46 (95% CI, 0.82-2.58), P = .20; primary induction failure versus ≥ relapse 1, RR, 0.84 (95% CI, 0.50-1.40), P = 0.49.